IDIBAPS creates Transplant Biotech, a spin off company for innovation in medical devices related to organ transplantation, metabolic, liver and kidney diseases

 On  Monday 3th of March it was celebrated the establishment of  Transplant Biotech S.L., the first spin -off 100 % IDIBAPS led by  IDIBAPS's researchers: Dr. Carmen Peralta, an expert in therapeutic  strategies in ischemia - reperfusion, with Dr. Anna Novials, expert in  diabetes, and Dr. Jordi Gracia, a specialist in vascular biology.

The participation of Dr. Peralta in BioEmprenedorXXI program, an  initiative of Biocat, la Caixa and Barcelona Activa, with the goal of  supporting entrepreneurship in the field of biotechnology and  biomedicine, has enabled the translation of a project research in a  business plan. Thanks to Dr. Josep Lluís Falco, project tutor assigned by the program, the research team was able to develop a business plan for innovation in medical devices related to organ transplantation, metabolic, liver and kidney disease.

The process has had the full support and backing IDIBAPS, the institution where the research and intellectual property of the project have been made. In addition, it has had the involvement of Mr. Ignasi Heras innovation expert and business development.

Photo (left to right): Mr. Ignasi Heras, Dr. Ramon Gomis (IDIBAPS director), Dr. Carmen Peralta, Dr. Josep Lluís Falcó, Dr.Jordi Gracia and Dr. Anna Novials.